XML 57 R37.htm IDEA: XBRL DOCUMENT
v3.20.2

Selected Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2020
Quarterly Financial Information Disclosure [Abstract] |
Schedule of Selected Quarterly Financial Data | The following is selected quarterly financial data for fiscal 2020 and 2019. The sum of the quarters may not equal year-to-date due to rounding.
(in millions, except per common share amounts) | First Quarter (1) |  | Second Quarter |  | Third Quarter |  | Fourth Quarter (2)
Fiscal 2020 |  |  |  |  |  |  |
Revenue | $ | 37,341 |  |  | $ | 39,735 |  |  | $ | 39,157 |  |  | $ | 36,689 |
Gross margin | 1,679 |  |  | 1,714 |  |  | 1,885 |  |  | 1,590 |
Distribution, selling, general and administrative expenses | 1,107 |  |  | 1,163 |  |  | 1,165 |  |  | 1,137 |
Net earnings/(loss) | (4,921 | ) |  | 220 |  |  | 351 |  |  | 657 |
Less: Net earnings attributable to noncontrolling interests | (1 | ) |  | — |  |  | (1 | ) |  | (1 | )
Net earnings/(loss) attributable to Cardinal Health, Inc. | (4,922 | ) |  | 220 |  |  | 350 |  |  | 656 |
Net earnings/(loss) attributable to Cardinal Health, Inc. per common share: |  |  |  |  |  |  |
Basic | $ | (16.65 | ) |  | $ | 0.75 |  |  | $ | 1.20 |  |  | $ | 2.25 |
Diluted | (16.65 | ) |  | 0.75 |  |  | 1.19 |  |  | 2.23 |
(1) | Includes a $5.63 billion pre-tax charge for the opioid litigation ($5.14 billion after tax).
(2) | Includes a $579 million pre-tax gain ($493 million after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.
(in millions, except per common share amounts) | First Quarter (1) |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Fiscal 2019 |  |  |  |  |  |  |
Revenue | $ | 35,213 |  |  | $ | 37,740 |  |  | $ | 35,228 |  |  | $ | 37,353 |
Gross margin | 1,667 |  |  | 1,730 |  |  | 1,764 |  |  | 1,674 |
Distribution, selling, general and administrative expenses | 1,155 |  |  | 1,064 |  |  | 1,097 |  |  | 1,168 |
Net earnings/(loss) | 594 |  |  | 281 |  |  | 296 |  |  | 194 |
Less: Net earnings attributable to noncontrolling interests | (1 | ) |  | (1 | ) |  | — |  |  | — |
Net earnings/(loss) attributable to Cardinal Health, Inc. | 593 |  |  | 280 |  |  | 296 |  |  | 194 |
Net earnings/(loss) attributable to Cardinal Health, Inc. per common share: |  |  |  |  |  |  |
Basic | $ | 1.95 |  |  | $ | 0.94 |  |  | $ | 0.99 |  |  | $ | 0.65 |
Diluted (3) | 1.94 |  |  | 0.93 |  |  | 0.99 |  |  | 0.65 |
(1) Includes a $508 million gain ($378 million after tax) related to the naviHealth divestiture.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration